Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Curr Org Synth ; 17(3): 243-250, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32096746

RESUMEN

Design of chemically novel, biologically potent small heterocyclic molecules with anticancer activities, which targets the enzyme heparanase has gained prominent clinical interest. We have synthesized a novel class of carboxamide derivatives by coupling various substituted aromatic acid hydrazides and triazoleamine with pyrrolidine carboxylic acid by using coupling agents. The synthesized compounds are characterized by spectroscopic techniques such as FT-IR, HRMS and NMR. These compounds are investigated for cytotoxicity on different cancer cell lines and heparanase inhibitory activity. Most of them showed moderate heparanase inhibitory activity and good cytotoxicity.


Asunto(s)
Antineoplásicos/farmacología , Inhibidores Enzimáticos/farmacología , Glucuronidasa/antagonistas & inhibidores , Hidrazinas/farmacología , Pirrolidinonas/farmacología , Triazoles/farmacología , Animales , Antineoplásicos/síntesis química , Línea Celular Tumoral , Inhibidores Enzimáticos/síntesis química , Humanos , Hidrazinas/síntesis química , Ratones , Pirrolidinonas/síntesis química , Triazoles/síntesis química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...